{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:46:01Z","timestamp":1789994761798,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danish National Research Foundation","doi-asserted-by":"publisher","award":["DNRF122"],"award-info":[{"award-number":["DNRF122"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008398","name":"Villum Foundation","doi-asserted-by":"publisher","award":["9301"],"award-info":[{"award-number":["9301"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Intelligent Drug delivery and sensing Using microcontainers and Nanomechanics (IDUN)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejpb.2019.08.011","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:50:15Z","timestamp":1565956215000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Microcontainers for oral insulin delivery \u2013 In vitro studies of permeation enhancement"],"prefix":"10.1016","volume":"143","author":[{"given":"Jacob Rune","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Leth","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Hagner","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dufva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne M\u00f8rck","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.08.011_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mee.2017.01.018","article-title":"Powder embossing method for selective loading of polymeric microcontainers with drug formulation","volume":"171","author":"Abid","year":"2017","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.ejpb.2019.08.011_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.aau2277","article-title":"An ingestible self-orienting system for oral delivery of macromolecules","volume":"363","author":"Abramson","year":"2019","journal-title":"Science"},{"issue":"Part B","key":"10.1016\/j.ejpb.2019.08.011_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev., Oral Del. Peptides: Opportunities Issues Translation"},{"key":"10.1016\/j.ejpb.2019.08.011_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0168-3659(02)00074-3","article-title":"Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery","volume":"81","author":"Ahmed","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.08.011_b0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2005.03.004","article-title":"Role of the mucous\/glycocalyx layers in insulin permeation across the rat ileal membrane","volume":"297","author":"Aoki","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0030","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol.-Gastrointest Liver Physiol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coph.2017.08.005","article-title":"Intestinal patch systems for oral drug delivery","volume":"36","author":"Banerjee","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.08.011_b0045","first-page":"361","article-title":"Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration","volume":"2","author":"Bernkop-Schn\u00fcrch","year":"1996","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejpb.2019.08.011_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery \u2013 understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejpb.2015.05.013","article-title":"Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol","volume":"94","author":"Brayden","year":"2015","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.ejpb.2019.08.011_b0060","doi-asserted-by":"crossref","first-page":"eaar7047","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2019.08.011_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(99)00213-6","article-title":"In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology","volume":"191","author":"Chao","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0070","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/adhm.201300676","article-title":"Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs","volume":"3","author":"Chirra","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2019.08.011_b0075","doi-asserted-by":"crossref","DOI":"10.4161\/21688370.2014.982426","article-title":"Roles and regulation of the mucus barrier in the gut","volume":"3","author":"Cornick","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejpb.2019.08.011_b0080","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s11095-004-7671-9","article-title":"Oral absorption enhancement of cromolyn sodium through noncovalent complexation","volume":"21","author":"Ding","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.08.011_b0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/17425247.2013.763792","article-title":"An update on pharmaceutical film coating for drug delivery","volume":"10","author":"Felton","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2019.08.011_b0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365521.2014.898326","article-title":"Surface area of the digestive tract - revisited","volume":"49","author":"Helander","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0095","article-title":"Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers","volume":"6","author":"Iyire","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2019.08.011_b0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2014.01.022","article-title":"Insulin diffusion and self-association characterized by real-time UV imaging and Taylor dispersion analysis","volume":"92","author":"Jensen","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2019.08.011_b0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/la990719o","article-title":"Cooperativity among Molecules at Interfaces in Relation to Various Technological Processes: Effect of Chain Length on the pKa of Fatty Acid Salt Solutions","volume":"16","author":"Kanicky","year":"2000","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2019.08.011_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2008.06.007","article-title":"Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: Characterization of conditions for affinity and transport experiments in Caco-2 cells","volume":"35","author":"Larsen","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.08.011_b0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/10611869808995876","article-title":"Absorption Enhancement in Intestinal Epithelial Caco-2 Monolayers by Sodium Caprate: Assessment of Molecular Weight Dependence and Demonstration of Transport Routes","volume":"5","author":"Lindmark","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2019.08.011_b0120","first-page":"1427","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Deliv. Rev., 2009 Editors\u2019 Collection"},{"issue":"Part B","key":"10.1016\/j.ejpb.2019.08.011_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev., Oral Del. Peptides: Opportunities Issues Translation"},{"key":"10.1016\/j.ejpb.2019.08.011_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1567201053586001","article-title":"Oral delivery of insulin with the eligen technology: mechanistic studies","volume":"2","author":"Malkov","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2019.08.011_b0135","doi-asserted-by":"crossref","first-page":"1900004","DOI":"10.1002\/mabi.201900004","article-title":"Polymeric Lids for Microcontainers for Oral Protein Delivery","volume":"19","author":"Mazzoni","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2019.08.011_b0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2017.10.013","article-title":"From concept to in vivo testing: Microcontainers for oral drug delivery","volume":"268","author":"Mazzoni","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.08.011_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: A mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejpb.2019.08.011_b0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","article-title":"Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts","volume":"101","author":"Moroz","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.08.011_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","article-title":"In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin","volume":"189","author":"Nielsen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.08.011_b0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejpb.2012.03.017","article-title":"Spatial confinement can lead to increased stability of amorphous indomethacin","volume":"81","author":"Nielsen","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2016.03.050","article-title":"Polymeric microcontainers improve oral bioavailability of furosemide","volume":"504","author":"Nielsen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0170","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejpb.2010.09.002","article-title":"In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules","volume":"76","author":"Parmentier","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0175","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.2042-7158.1998.tb03319.x","article-title":"Biopharmaceutics: Cytotoxicity of Absorption Enhancers in Caco-2 Cell Monolayers","volume":"50","author":"Sakai","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1271\/bbb.63.680","article-title":"Recovery of Caco-2 Cell Monolayers to Normal from the Transport-enhanced State Induced by Capric Acid Sodium Salt and its Monoacylglycerol","volume":"63","author":"Shima","year":"1999","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejpb.2019.08.011_b0185","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/17425247.2014.917077","article-title":"Oral peptide and protein delivery: intestinal obstacles and commercial prospects","volume":"11","author":"Smart","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2019.08.011_b0190","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal Permeability Enhancement: Efficacy, Acute Local Toxicity, and Reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.08.011_b0195","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/nprot.2006.451","article-title":"Off-wafer fabrication and surface modification of asymmetric 3D SU-8 microparticles","volume":"1","author":"Tao","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2019.08.011_b0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","article-title":"Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation","volume":"210","author":"Taverner","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.08.011_b0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit\u00ae: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2019.08.011_b0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jps.24182","article-title":"Microneedles for Drug Delivery via the Gastrointestinal","volume":"104","author":"Traverso","year":"2015","journal-title":"Tract. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.08.011_b0215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.2042-7158.2011.01399.x","article-title":"Mucus thickness in the gastrointestinal tract of laboratory animals","volume":"64","author":"Varum","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.08.011_b0220","series-title":"Additive Manufacturing and Characterization of Mini Devices for Oral Drug Delivery","author":"Vaut","year":"2019"},{"key":"10.1016\/j.ejpb.2019.08.011_b0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/tde.10.5","article-title":"Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate","volume":"1","author":"Wang","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2019.08.011_b0230","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2013.12.017","article-title":"The role of citric acid in oral peptide and protein formulations: Relationship between calcium chelation and proteolysis inhibition","volume":"86","author":"Welling","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.08.011_b0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","article-title":"Oral delivery of macromolecules using intestinal patches: applications for insulin delivery","volume":"98","author":"Whitehead","year":"2004","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111930668X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111930668X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:39:13Z","timestamp":1568903953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111930668X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"alternative-id":["S093964111930668X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.08.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microcontainers for oral insulin delivery \u2013 In vitro studies of permeation enhancement","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}